Category: Generics Drugs
Global Generics Drugs
-
Generic Drugs Market Report by Therapy Area (Central Nervous System, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Retail Pharmacies, Hospital Pharmacies), and Country 2024-2032
... global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032. The ... Read More
-
Generic Injectables Global Market Report 2024
... Pharmacy; Retail Pharmacy; Drug Stores; Online Prescription Stores5) By Application: Oncology; Diabetes; Infectious Diseases; Blood Disorders; Musculoskeletal Disorders; Hormonal Disorders; Pain Management; CNS Diseases; Cardiovascular DiseasesCovering: Baxter International Inc.; Sanofi SA; AstraZeneca plc.; Fresenius Medical ... Read More
-
Pharmaceutical Marketing Market by Category (Conference Marketing, PPC Advertising, Print Advertising), Distribution (Generic Drug Marketing, Institutional Supply, Online Pharmacies), Business Model - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 46.03 billion in 2024, at a CAGR 12.26% to reach USD 92.55 billion by 2030. Global Pharmaceutical Marketing Market The pharmaceutical market, comprising the discovery, development, production, ... Read More
-
Specialty Generics Market by Type (Injectables, Oral Drugs), Application (Hepatitis C, Inflammatory Conditions, Multiple Sclerosis), End-Use - Global Forecast 2024-2030
... to reach USD 93.56 billion in 2024, at a CAGR 10.73% to reach USD 173.25 billion by 2030. Global Specialty Generics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Specialty ... Read More
-
Gastroesophageal Reflux Disease Therapeutics Market by Type (Branded, Generics), Drug Class (Aminosalicylates, Anti-Diarrheal, Anti-Emetics), Application - Global Forecast 2024-2030
... expected to reach USD 6.14 billion in 2024, at a CAGR 5.01% to reach USD 8.24 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Gastroesophageal Reflux Disease Therapeutics ... Read More
-
Antiviral Drugs Market by Drug Type (Branded Drugs, Generic Drugs), Therapeutics (Acquired Immunodeficiency Syndrome Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics), End Use - Global Forecast 2024-2030
... at USD 56.22 billion in 2023 and expected to reach USD 59.84 billion in 2024, at a CAGR 6.54% to reach USD 87.61 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Global Forecast 2024-2030
... and expected to reach USD 1.08 billion in 2024, at a CAGR 6.49% to reach USD 1.58 billion by 2030. Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method ... Read More
-
Fondaparinux Market by Product (Branded, Generics), Application (Ambulatory Surgical Centres, Clinics, Diagnostic centers) - Global Forecast 2024-2030
... million in 2024, at a CAGR 6.57% to reach USD 637.49 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Fondaparinux Market. It offers a comprehensive assessment of vendors, ... Read More
-
Generic Injectables Market by Product (Large Molecule Injectables, Small Molecule Injectables), Type (Cytokines, Insulin, Monoclonal Antibodies), Application, Distribution Channel - Global Forecast 2024-2030
... 2023 and expected to reach USD 33.12 billion in 2024, at a CAGR 10.57% to reach USD 60.66 billion by 2030. Global Generic Injectables MarketGeneric injectables are non-branded pharmaceuticals that are administered by injection and ... Read More
-
High Potency API Contract Manufacturing Market by Product Type (Generics, Innovative), Synthesis (Biotech, Synthetic), Dosage Form, Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 12.95 billion in 2024, at a CAGR 10.24% to reach USD 23.36 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the High ... Read More
-
Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2024-2030
... expected to reach USD 19.03 billion in 2024, at a CAGR 8.78% to reach USD 31.56 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Anxiety Drugs Market. It ... Read More
-
Global Markets for Generic Drugs
... report covers small molecule drugs and biosimilars. It includes market drivers and challenges in the generic drug industry. The competitive landscape includes generic drug sales of key competitors and their ranking in the market. It ... Read More
-
Generic Musculoskeletal Disorders Drugs Global Market Report 2024
... By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Drug Store; Online PharmacyCovering: Pfizer Inc.; Sanofi S.A.; Eli Lilly and Company; Ampio Pharmaceuticals Inc.; Amgen Inc. Generic Musculoskeletal Disorders Drugs Global Market Report 2024 from The Business ... Read More
-
Global Inhalation and Nasal Sprays Generic Drugs Market Research Report 2024(Status and Outlook)
... of countries where they are dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Inhalation ... Read More
-
Global Inhalation and Nasal Spray Generic Drugs Market Research Report 2024(Status and Outlook)
... of countries where they are dispensed. According to US FDA, A generic drug is identical--or bioequivalent--to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Inhalation ... Read More
-
Global Specialty Injectable Generics Market Research Report 2024(Status and Outlook)
... by 2029, exhibiting a CAGR of 8.40% during the forecast period. This report provides a deep insight into the global Specialty Injectable Generics market covering all its essential aspects. This ranges from a macro overview ... Read More
-
Global Dementia and Movement Disorder Treatment Market 2024-2028
... The report on the dementia and movement disorder treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Pulmonary Arterial Hypertension Market Forecasts to 2030 – Global Analysis By Type (Innovative, Generics and Other Types), Product (Endothelin Receptor Antagonists, Soluble Guanylate Cyclase (sGC) Stimulators, Phosphodiesterase-5 (PDE-5) Inhibitors, Prostacyclin Analogs and Other Products), Route of Administration, End User and By Geography
... of Administration, End User and By Geography According to Stratistics MRC, the Global Pulmonary Arterial Hypertension Market is accounted for $5.4 billion in 2023 and is expected to reach $8.9 billion by 2030 growing at ... Read More
-
2024 Global Forecast for Branded Generics (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Chemical Manufacturing industry. The product or service category is within the NAICS Chemical Manufacturing industry. The global market is expected to increase from USD xx billion in 2025 ... Read More
-
Dyspepsia Drugs Market - Indication (Functional, Organic), Drug Type (Proton Pump Inhibitors, H-2-Receptor Antagonists, Antacids, Antibiotics), Medication (Branded, Generic), Mode (OTC, Prescription), Distribution Channel, Global Forecast (2024-2032)
... CAGR from 2024 to 2032 owing to the escalating incidence of digestive disorders across demographics. The modern lifestyle, characterized by erratic eating habits, increased stress levels, and sedentary behavior, has contributed to a surge in ... Read More
-
Digital Dose Inhaler Market by Product (Dry Powder Inhalers, Metered Dose Inhalers), Type (Branded Medication, Generics Medication), Distribution, Application - Global Forecast 2023-2030
... in 2022 and expected to reach USD 1,046.61 million in 2023, at a CAGR 10.29% to reach USD 2,083.52 million by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Digital ... Read More
-
Specialty Generics Global Market Report 2024
... International plc; Akorn Operating Company LLC ; Mylan NV; MallInc.krodt Pharmaceuticals Specialty Generics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to ... Read More
-
Global Generic Drugs Market Assessment, By Application [Neurovascular, Cardiovascular, Dermatology, Oncology, Respiratory, Diabetology and Others], By Type [Biosimilar Generics, Small Molecule Generics], By Brand [Branded Generic, Pure Generic], By Route of Administration [Oral, Injectable, Topical and Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities, and Forecast, 2016-2030F
... and Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities, and Forecast, 2016-2030F The Global Generic Drugs market size was estimated at USD 335.65 billion in 2022 and is projected to ... Read More
-
Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Global Market Opportunities And Strategies To 2032
... Development And Manufacturing; Secondary Packagingb) By CRO Service: Preclinical; Phase I; Phase II; Phase III; Phase IV2)By End User: Big Pharmaceutical Companies; Generic Pharmaceutical Companies; Small And Medium-Sized Pharmaceutical CompaniesCovering: Lonza Group; Catalent Inc.; WuXi ... Read More
-
Oral Solid dosage (OSD) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product (Tablets, Capsules, Powders, Granules, Others), By End User (Large-size companies, Small & medium size companies, Startups and generic pharmaceutical companies), By Region and Competition
... Startups and generic pharmaceutical companies), By Region and Competition Global Oral Solid dosage (OSD) Contract Manufacturing Market has valued at USD 33.45 billion in 2022 and is anticipated to project impressive growth in the forecast ... Read More
Research Assistance
